|
KIAA0174 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.08340003635021E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.34919999617011E-08 |
| Normal-vs-Stage2 |
3.141000E-03 |
| Normal-vs-Stage3 |
3.10139691706013E-11 |
| Normal-vs-Stage4 |
2.2127000232075E-09 |
| Stage1-vs-Stage2 |
2.447600E-01 |
| Stage1-vs-Stage3 |
3.837500E-03 |
| Stage1-vs-Stage4 |
2.284500E-03 |
| Stage2-vs-Stage3 |
7.001100E-03 |
| Stage2-vs-Stage4 |
3.076600E-03 |
| Stage3-vs-Stage4 |
5.192400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.5613999810048E-10 |
| Normal-vs-AfricanAmerican |
1.150020E-04 |
| Normal-vs-Asian |
1.55759999997951E-06 |
| Caucasian-vs-AfricanAmerican |
9.543400E-01 |
| Caucasian-vs-Asian |
2.589200E-01 |
| AfricanAmerican-vs-Asian |
5.388600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.10940000098392E-08 |
| Normal-vs-Female |
6.50089981846236E-11 |
| Male-vs-Female |
3.382800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.18360000023188E-07 |
| Normal-vs-Age(41-60Yrs) |
6.89559997990585E-09 |
| Normal-vs-Age(61-80Yrs) |
2.45940046106341E-10 |
| Normal-vs-Age(81-100Yrs) |
2.737400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.952400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.832300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.563800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.794040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.294800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.692600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.822300E-04 |
| Classical-VS-Follicular |
4.652200E-01 |
| Classical-VS-Other |
3.984800E-01 |
| Classical-VS-Normal |
4.69349999976387E-07 |
| Tall-VS-Follicular |
3.021300E-03 |
| Tall-VS-Other |
3.129200E-01 |
| Tall-VS-Normal |
1.71299641138489E-11 |
| Follicular-VS-Other |
6.162400E-01 |
| Follicular-VS-Normal |
1.15580000004112E-06 |
| Other-VS-Normal |
2.877000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.7990000013628E-09 |
| Normal-vs-N1 |
3.02909919369654E-11 |
| N0-vs-N1 |
9.004900E-04 |
|
|
